Search

everythinglearnresearchcommunity

for

Search:↓

Afatinib often causes skin problems that need proactive management.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Social media can help compare the effectiveness and safety of new arthritis medications.

Different parts of the body have unique immune characteristics in their skin.

AGA might indicate higher risk for severe COVID-19.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Research on "hair cloning" for hair loss shows potential for hair thickening but has not yet achieved new hair growth in humans.

PBMCsec can help reduce and improve thick skin scars.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Human dermal papilla cells can increase hair thickness and number in pigs with just one injection.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Activating Nrf2 can help protect against hearing loss.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.